Related Experiment Video
Updated: Jun 2, 2026
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
In silico analysis of combinatorial microRNA activity reveals target genes and pathways associated with breast cancer
Alan A Dombkowski1, Zakia Sultana, Douglas B Craig
1Division of Clinical Pharmacology and Toxicology, Department of Pediatrics, Wayne State University School of Medicine, Detroit, MI, USA.
Abstract:
Aberrant microRNA activity has been reported in many diseases, and studies often find numerous microRNAs concurrently dysregulated. Most target genes have binding sites for multiple microRNAs, and mounting evidence indicates that it is important to consider their combinatorial effect on target gene repression. A recent study associated the coincident loss of expression of six microRNAs with metastatic potential in breast cancer. Here, we used a new computational method, miR-AT!, to investigate combinatorial activity among this group of microRNAs. We found that the set of transcripts having multiple target sites for these microRNAs was significantly enriched with genes involved in cellular processes commonly perturbed in metastatic tumors: cell cycle regulation, cytoskeleton organization, and cell adhesion. Network analysis revealed numerous target genes upstream of cyclin D1 and c-Myc, indicating that the collective loss of the six microRNAs may have a focal effect on these two key regulatory nodes. A number of genes previously implicated in cancer metastasis are among the predicted combinatorial targets, including TGFB1, ARPC3, and RANKL. In summary, our analysis reveals extensive combinatorial interactions that have notable implications for their potential role in breast cancer metastasis and in therapeutic development.
Insights
The loss of six microRNAs in breast cancer is linked to metastasis. A new computational method, miR-AT!, reveals these microRNAs collectively regulate key genes involved in cancer progression.
Area of Science:
- Molecular Biology
- Genomics
- Cancer Research
Background:
- Aberrant microRNA (miRNA) activity is implicated in numerous diseases, with multiple miRNAs often dysregulated simultaneously.
- MicroRNAs play a crucial role in gene regulation, and their combinatorial effects on target gene repression are increasingly recognized as significant.
- A prior study linked the concurrent loss of six specific miRNAs to enhanced metastatic potential in breast cancer.
Purpose of the Study:
- To investigate the combinatorial activity of a specific group of six microRNAs using a novel computational approach.
- To identify target genes regulated by the combinatorial action of these six microRNAs.
- To explore the implications of these combinatorial interactions in breast cancer metastasis.
Main Methods:
- Development and application of a new computational method, miR-AT!, for analyzing microRNA combinatorial activity.
- Identification of transcripts with multiple binding sites for the studied microRNAs.
- Network analysis to identify key regulatory nodes targeted by the microRNAs.
Main Results:
- The set of transcripts targeted by multiple sites for these six miRNAs was significantly enriched with genes involved in cell cycle regulation, cytoskeleton organization, and cell adhesion.
- Network analysis indicated that the collective loss of these miRNAs may have a focal effect on key regulatory nodes such as cyclin D1 and c-Myc.
- Predicted combinatorial targets include genes previously implicated in cancer metastasis, such as TGFB1, ARPC3, and RANKL.
Conclusions:
- The analysis revealed extensive combinatorial interactions among the six studied microRNAs.
- These interactions have significant implications for their collective role in breast cancer metastasis.
- Understanding these combinatorial effects is crucial for developing targeted therapeutic strategies.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs